Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
NICE is adamant about rejecting a medicine for a rare condition
The UK’s National Institute for Health and Care Excellence (NICE) has issued its final verdict on Clinuvel’s Scenesse, a treatment ...
Pre-launch KOL conversations may have increased medicine uptake by 1.5 times
Source – Veeva Systems An analysis conducted by Veeva Systems suggests that effective engagement between medical science liaisons (MSLs) and ...
Balfaxar, a warfarin reversal medication from Octapharma, receives FDA approval
Source – Octapharma More than 2.4 million individuals in the United States rely on warfarin, a blood thinner, to prevent ...
After winning the J&J arbitration dispute, Alkermes, which is close to splitting its oncology business, saw a significant Q2 revenue increase
Alkermes is feeling confident about its prospects for the second half of 2023, after winning a big arbitration case against ...
GSK lowers short-term hopes for RSV treatment Arexvy but raises 2023 forecast
Great expectations surround GSK’s entry into the respiratory syncytial virus (RSV) vaccine market with their upcoming shot, Arexvy, set to ...
GSK’s Arexvy and Moderna’s mRNA-1345 to lead the race for RSV prevention
The respiratory syncytial virus (RSV) is a common cause of respiratory infections, especially in infants and older adults. It can ...
A New Hope for Children and Teens with gMG: Soliris Gets EU Approval
Source – AstraZeneca The European Union (EU) has granted approval for the expanded use of Soliris (eculizumab) to treat refractory ...
Expanding their strategic partnership, AbbVie and Calibr aim to advance a number of preclinical and early-stage clinical assets
Source – AbbVie On July 26, 2023, AbbVie and Calibr announced expanded strategic collaboration to advance several innovative preclinical and ...
Merck and Moderna Commence Phase III Study of V940 with KEYTRUDA for High-Risk Melanoma
Source – Merck Moderna and Merck announced the commencement of the pivotal Phase III randomized V940-001 clinical trial. This trial ...
Eversana and Amazon are planning an AI-driven drug push
Source – Eversana Eversana and Amazon Web Services (AWS) have formed an alliance to accelerate the adoption of generative artificial ...
With the PeptiDream agreement, Astellas incorporates protein degraders
Source – Astellas Astellas has continued its focus on protein degrader drugs, announcing its second partnership in this category in ...
Jardiance Receives EU Approval for Treating Chronic Kidney Disease (CKD), Posing a Strong Challenge to Forxiga
Source – Boehringer Ingelheim The European Union has granted approval for Boehringer Ingelheim and Eli Lilly’s SGLT2 inhibitor, Jardiance (empagliflozin), ...
Bayer anticipates a more bleak 2023 as decreased glyphosate sales support the argument for a separation
As calls for a business separation at Bayer grow louder, the company’s weedkiller performance is providing further support for the ...
Tarsus’ Xdemvy is approved by the FDA as the first therapy for common eyelid illness
Source – Tarsus Pharmaceuticals Tarsus Pharmaceuticals has achieved a groundbreaking milestone with the FDA approval of Xdemvy, the first-ever treatment ...
FibroGen CEO Conterno Resigns Amid Roxadustat Launch Setbacks
Source – FibroGen Enrique Conterno, who became FibroGen’s CEO in early 2020, had high hopes for the anemia drug roxadustat ...
Biogen anticipates 1,000 further layoffs by 2025 as it navigates a “transition”
Source – Biogen During the announcement of its first-quarter earnings, Biogen revealed its strategic decision to discontinue the development of ...
Cabometyx patent battle is resolved by Exelixis and Teva with a 2031 generic license
Source – Exelixis Exelixis, the company behind the successful cancer drug Cabometyx, has been actively defending its intellectual property. In ...
Continue to Evaluate TTFields in Pancreatic Cancer in the PANOVA-3 Trial
Source – Novocure The Phase III PANOVA-3 trial, which is assessing Tumor Treating Fields (TTFields) therapy in combination with nab-paclitaxel ...
Magrolimab for myelodysplastic syndromes is discontinued by Gilead
Source – Gilead Science Gilead Sciences has announced the discontinuation of its cancer antibody, magrolimab, in the treatment of blood ...
Patients prefer ViiV’s injectable HIV medication, according to a Switch research
When ViiV Healthcare and Johnson & Johnson introduced their once-monthly injectable HIV treatment Cabenuva in 2021, they anticipated that patients ...
Johnson & Johnson intends to trade 80% of its Kenvue stock after the consumer split
Source – Johnson & Johnson With the completion of Johnson & Johnson’s consumer health spinoff, the company is now redirecting ...
FDA Greenlights Verrica Pharmaceuticals’ Ycanth (cantharidin) Topical Solution 0.7%
Source – Verrica Pharmaceuticals After facing two rejections from the FDA, both related to manufacturing issues, Verrica Pharmaceuticals has finally ...
Teva Expands Alvotech Collaboration with 2 New Biosimilar, $40M Investment & Enhanced Oversight
Source – Teva Pharmaceuticals Following the second FDA rejection of Teva’s Alvotech-partnered biosimilar for Humira, the two companies are expanding ...
FDA issues a warning notice to Centaur Pharmaceuticals detailing quality and sanitation violations
Centaur Pharmaceuticals, a company based in India, recently faced scrutiny from the FDA due to issues discovered during an inspection ...
Powerful Alliance: AstraZeneca Teams Up with SK Chemicals to Revolutionize Diabetes Treatment with Sidapvia Combo Drug
Korea’s SK Chemicals has recently entered into an agreement with AstraZeneca to manufacture the diabetes drug Sidapvia for the remainder ...
Merck’s Gefapixant Receives Positive EU CHMP Opinion
Source – Merck MSD has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has ...
Twice-Yearly Lenacapavir Boosts HIV Patients’ Quality of Life
Source – Gilead Gilead Sciences presented new data at the 12th International AIDS Society (IAS) Conference on HIV Science (IAS ...
AbbVie’s Epcoritamab (EPKINLY) Receives Positive CHMP Opinion for DLBCL Treatment
Source – AbbVieAbbVie and Genmab’s potential blockbuster drug epcoritamab has received a favorable recommendation for conditional approval in the EU ...
Less than anticipated supply impact from Pfizer’s tornado-damaged factory
The FDA has addressed the impact of the recent devastating tornado that hit Pfizer’s Rocky Mount facility in North Carolina. ...
Teva Introduces a Smart Inhaler That Could Revolutionize Asthma Management
Teva has introduced a digitally-enabled inhaler called GoResp Digihaler in the UK, making it the first European market to receive ...
